poisar

Stocks · News reference

Inogen Reports Q3 2026 Results, Appoints New CEO, and Announces Strategic Divestiture

Inogen, Inc. announced its third-quarter 2026 financial results, the appointment of Andy Reding as CEO, and the sale of its U.S. oxygen rental business as part of a strategic restructuring.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

INGN
Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Motley Fool Transcribing

    Inogen (INGN) Q3 2026 Earnings Call Transcript

    Inogen reported Q3 2026 results showing mixed performance with U.S. sales growth of 3.8% driven by new products, but international sales declined 9% due to European customer softness. The company divested its U.S. oxygen rental business for $24.8 million and announced a $20 million cost-reduction program to accelerate profitability. New CEO Andrew Reding outlined plans to streamline operations and expand into adjacent respiratory markets with Aurora and Voxi products. Full-year revenue guidance is $298-301 million with adjusted net loss of $7-8 million.

    INGN
  2. Benzinga Insights

    Full Transcript: Inogen Q2 2026 Earnings Call

    Inogen (NASDAQ:INGN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our

    INGN
  3. SEC EDGAR

    8-K filing — Inogen Inc (INGN)

    Filed: 2026-09-30 AccNo: 0001294133-26-000037 Size: 195 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

    INGN